SEC Form 4

FORM 4		UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940	OMB APPROVAL OMB Number: 3235-0287 Estimated average burden hours per response: 0.5
X	Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person* RUNNELLS JOHN E (Last) (First) (Middle) C/O THE VERTICAL GROUP 106 ALLEN ROAD SUITE 207 (Street) BASKING RIDGE NJ 07920 (City) (State) (Zip)	2. Issuer Name and Ticker or Trading Symbol Silk Road Medical Inc [ SILK ]	5. Relationship of Reporting Person(s) to Issuer (Check all applicable) Director 10% Owner Officer (give title below) X Other (specify below) Former 10% Owner
	3. Date of Earliest Transaction (Month/Day/Year) 10/01/2019
	4. If Amendment, Date of Original Filed (Month/Day/Year)	6. Individual or Joint/Group Filing (Check Applicable Line) X Form filed by One Reporting Person Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	10/01/2019		J		810,284(3)	D	$0	49,212	I	See Footnote(1)(2)
Common Stock	10/01/2019		J		136,341(5)	A	$0	3,555,794	I	See Footnote(1)(4)
Common Stock	10/01/2019		J		3,358,939(6)	D	$0	196,855	I	See Footnote(1)(4)
Common Stock	10/01/2019		J		40,948(8)	A	$0	41,689	I	See Footnote(1)(7)
Common Stock	10/01/2019		J		850,875(10)	A	$0	850,875	I	See Footnote(1)(9)
Common Stock	10/01/2019		J		3,967(12)	A	$0	3,967	I	See Footnote(11)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The Vertical Group, L.P., a Delaware limited partnership, is the sole general partner of each of Vertical Fund I, L.P. ("VFI") and Vertical Fund II, L.P. ("VFII"), and The Vertical Group GP, LLC, a Delaware limited liability company, controls The Vertical Group, L.P. The sole members and managers of The Vertical Group GP, LLC are Messrs. Tony M. Chou, Richard B. Emmitt, Jack W. Lasersohn and John E. Runnells. Per agreement of the parties, Messrs. Chou and Lasersohn have no investment or voting power over Silk Road Medical, Inc. securities held by VFI, VFII, The Vertical Group, Inc. ("VGI") and The Vertical Group, L.P., while Messrs. Emmitt and Runnells share voting and investment power over such securities. Mr. Runnells disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein.

2. These shares are held directly by VFII.

3. VFII distributed the shares to its partners on a pro rata basis.

4. These shares are held directly by VFI.

5. Of the shares distributed by VFII, 136,341 of such shares were distributed to VFI in accordance with its pro rata partnership interest in VFII.

6. VFI distributed the shares to its partners on a pro rata basis.

7. These share are held directly by VGI.

8. Of the shares distributed by VFII and VFI, 40,948 of such shares were distributed to VGI in accordance with its pro rata partnership interest in VFII and VFI, respectively.

9. These shares are held directly by The Vertical Group, L.P.

10. Of the shares distributed by VFII and VFI, 850,875 of such shares were distributed to The Vertical Group, L.P. in accordance with its pro rata partnership interest in VFII and VFI, respectively.

11. These shares are held directly by Mr. Runnells' wife.

12. Of the shares distributed by VFI, 3,967 of such shares were distributed to Mr. Runnells' wife in accordance with her pro rata partnership interest in VFI.

	/s/ John E. Runnells	10/03/2019
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.